Allergy Asthma Respir Dis.  2013 Jun;1(2):138-143. 10.4168/aard.2013.1.2.138.

Correlation between serum 25-hydroxyvitamin D levels and methicillin - resistant Staphylococcus aureus skin colonization in atopic dermatitis

• Min TK
• Yang HJ
• Lee HW
• Pyun BY

• KMID: 2261861
• DOI: http://doi.org/10.4168/aard.2013.1.2.138

Abstract

PURPOSE
Bacterial infection with Staphylococcus aureus is a common complication of atopic dermatitis (AD) and involved in the worsening of this disease. Recent studies have revealed an increasing prevalence of community-associated methicillin-resistant S. aureus (MRSA) among patients with AD and the role of vitamin D in the immunopathogenesis of AD. We carried out a study to see whether levels of vitamin D correlate with MRSA skin colonization in AD.
METHODS
Total 60 patients with AD aged between 3 months and 6 years old were enrolled. We measured disease severity using the Scoring Atopic Dermatitis (SCORAD) index, serum levels of 25-hydroxyvitamin D (25(OH)D), total immunoglobulin E levels, eosinophil cationic protein and bacterial colonization by skin swab and culture method.
RESULTS
S. aureus was cultured in 20 patients of the total (33.3%). MRSA was comprised 35% of the S. aureus-positive group. SCORAD value was significantly higher in S. aureus-positive group. Serum levels (mean+/-standard deviation) of 25(OH)D were lower in MRSA group (22.6+/-11.5 ng/mL) compared with those of methicillin-sensitive S. aureus group (31.3+/-10.2 ng/mL) or S. aureus negative group (34.3+/-15.8 ng/mL). But there was no statistically significant difference.
CONCLUSION
Our study shows that the serum levels of 25(OH)D were lower in MRSA group. But there was no statistically significant difference. Therefore further studies including large numbers of cases are necessary.

Keyword

Vitamin D; Methicillin-resistant Staphylococcus aureus; Atopic dermatitis

MeSH Terms

Aged
Bacterial Infections
Colon
Dermatitis, Atopic
Eosinophil Cationic Protein
Humans
Immunoglobulin E
Immunoglobulins
Methicillin
Methicillin Resistance
Methicillin-Resistant Staphylococcus aureus
Prevalence
Skin
Staphylococcus
Staphylococcus aureus
Vitamin D
Eosinophil Cationic Protein
Immunoglobulin E
Immunoglobulins
Methicillin
Vitamin D

Figure

• 

  Fig. 1 Correlation between serum vitamin D levels and individual SCORAD values. SCORAD, scoring of atopic dermatitis; 25(OH)D, 25-hydroxyvitamin D.

Reference

1. Leung DY, Bieber T. Atopic dermatitis. Lancet. 2003; 361:151–160.

2. Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006; 368:733–743.

3. Ahn K, Kim J, Kwon HJ, Chae Y, Hahm MI, Lee KJ, et al. The prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in Korean children: nationwide cross-sectional survey using complex sampling design. J Korean Med Assoc. 2011; 54:769–778.

4. Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol. 2006; 118:152–169.

5. Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol. 1974; 90:525–530.

6. Williams RE, Gibson AG, Aitchison TC, Lever R, Mackie RM. Assessment of a contact-plate sampling technique and subsequent quantitative bacterial studies in atopic dermatitis. Br J Dermatol. 1990; 123:493–501.

7. Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics. 2009; 123:e808–e814.

8. Akiyama H, Yamasaki O, Tada J, Arata J. Adherence characteristics and susceptibility to antimicrobial agents of Staphylococcus aureus strains isolated from skin infections and atopic dermatitis. J Dermatol Sci. 2000; 23:155–160.

9. Nishijima S, Kurokawa I, Nakaya H. Susceptibility change to antibiotics of Staphylococcus aureus strains isolated from skin infections between July 1994 and November 2000. J Infect Chemother. 2002; 8:187–189.

10. Suh L, Coffin S, Leckerman KH, Gelfand JM, Honig PJ, Yan AC. Methicillin-resistant Staphylococcus aureus colonization in children with atopic dermatitis. Pediatr Dermatol. 2008; 25:528–534.

11. Boguniewicz M, Leung DY. Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol. 2010; 125:4–13.

12. Schlievert PM, Strandberg KL, Lin YC, Peterson ML, Leung DY. Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. J Allergy Clin Immunol. 2010; 125:39–49.

13. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357:266–281.

14. Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M. Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics. 2008; 122:398–417.

15. Dimeloe S, Nanzer A, Ryanna K, Hawrylowicz C. Regulatory T cells, inflammation and the allergic response: the role of glucocorticoids and Vitamin D. J Steroid Biochem Mol Biol. 2010; 120:86–95.

16. Morales-Tirado V, Wichlan DG, Leimig TE, Street SE, Kasow KA, Riberdy JM. 1α,25-dihydroxyvitamin D3 (vitamin D3) catalyzes suppressive activity on human natural regulatory T cells, uniquely modulates cell cycle progression, and augments FOXP3. Clin Immunol. 2011; 138:212–221.

17. van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol. 2005; 97:93–101.

18. Searing DA, Leung DY. Vitamin D in atopic dermatitis, asthma and allergic diseases. Immunol Allergy Clin North Am. 2010; 30:397–409.

19. Gurlek A, Pittelkow MR, Kumar R. Modulation of growth factor/cytokine synthesis and signaling by 1alpha,25-dihydroxyvitamin D(3): implications in cell growth and differentiation. Endocr Rev. 2002; 23:763–786.

20. Schauber J, Gallo RL. Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol. 2008; 122:261–266.

21. Matheson EM, Mainous AG 3rd, Hueston WJ, Diaz VA, Everett CJ. Vitamin D and methicillin-resistant Staphylococcus aureus nasal carriage. Scand J Infect Dis. 2010; 42:455–460.

22. Kunz B, Oranje AP, Labreze L, Stalder JF, Ring J, Taieb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997; 195:10–19.

23. Elias PM, Menon GK. Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res. 1991; 24:1–26.

24. Elias PM, Hatano Y, Williams ML. Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol. 2008; 121:1337–1343.

25. Rhim JW, Moon KS, Kong DY, Pyun BY. An Investigation into the actual condition of outbreak and treatment in atopic dermatitis. Pediatr Allergy Respir Dis. 2005; 15:44–52.

26. Ban HR, Lee SY, Choi J, Kim HB, Song YW, Kim BJ, et al. Staphylococcus aureus colonization and atopic dermatitis: relation to clinical characteristics. Korean J Asthma Allergy Clin Immunol. 2008; 28:105–112.

27. Kim YS, Lee JH, Kim ES, Yang HJ, Kong DY, Choi TY, et al. Secondary skin infection and their sensitivity to antibiotics in children's atopic dermatitis. Pediatr Allergy Respir Dis. 2006; 16:26–37.

28. Kim YH, Lee ES, Kim JS, Kim MJ, Jung JA, Yang S, et al. The effect of skin-colonizing staphylococcus aureus and its exotoxins on childhood atopic dermatitis. Pediatr Allergy Respir Dis. 2006; 16:162–170.

29. Higaki S, Morohashi M, Yamagishi T, Hasegawa Y. Comparative study of staphylococci from the skin of atopic dermatitis patients and from healthy subjects. Int J Dermatol. 1999; 38:265–269.

30. Izadpanah A, Gallo RL. Antimicrobial peptides. J Am Acad Dermatol. 2005; 52(3 Pt 1):381–390.

31. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002; 347:1151–1160.

32. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004; 173:2909–2912.

33. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006; 311:1770–1773.

34. Peroni DG, Piacentini GL, Cametti E, Chinellato I, Boner AL. Correlation between serum 25-hydroxyvitamin D levels and severity of atopic dermatitis in children. Br J Dermatol. 2011; 164:1078–1082.

35. Leung DY. Atopic dermatitis. In : Leung DY, Sampson HA, Geha RS, Szefler SJ, editors. Pediatric allergy: principles and practice. St. Louis: Mosby;2003. p. 561–571.

36. Hata TR, Kotol P, Jackson M, Nguyen M, Paik A, Udall D, et al. Administration of oral vitamin D induces cathelicidin production in atopic individuals. J Allergy Clin Immunol. 2008; 122:829–831.

37. Sidbury R, Sullivan AF, Thadhani RI, Camargo CA Jr. Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study. Br J Dermatol. 2008; 159:245–247.